搜索结果：Recent advances in drug delivery and formulation

The development of statistical physics in Africa is in its nascent stages, yet its application holds immense promise for advancing emerging research trends on the continent. This perspective paper, a product of a two-week workshop on biophysics in Morogoro (Tanzania), aims to illuminate the potential of statistical physics in regional scientific research. We employ in-silico atomistic molecular dynamics simulations to investigate the loading and delivery capabilities of lecithin nanolipids for niclosamide, a poorly water-soluble drug. Our simulations reveal that the loading capacity and interaction strength between lecithin nanolipids and niclosamide improve with increased lecithin concentrations. We perform a free-energy landscape analysis which uncovers two distinct metastable conformations of niclosamide within both the aqueous phase and the lecithin nanolipids. Over a simulation period of half a microsecond, lecithin nanolipids self-assemble into a spherical monolayer structure, providing detailed atomic-level insights into their interactions with niclosamide. These findings underscore the potential of lecithin nanolipids as efficient drug delivery systems.

Improving the efficacy of nasal sprays by enhancing targeted drug delivery to intra-airway tissue sites prone to infection onset is hypothesized to be achievable through an optimization of key device and formulation parameters, such as the sprayed droplet sizes, spray cone angle, and formulation density. This study focuses on the nasopharynx, a primary locus of early viral entry, as the optimal target for intranasal drug delivery. 3D anatomical upper airway geometries reconstructed from high-resolution computed tomography scans were used to numerically evaluate a cone injection approach, with inert particles mimicking the motion of sprayed droplets within an underlying inhaled airflow field. We have considered monodisperse sprayed particles sized between 10 to 50 microns, six densities ranging from 1.0 to 1.5 g/ml for the constituent formulation, and twelve plume angles spanning 1 to 70 degrees subtended by the spray jet at the nozzle position. Large Eddy Simulation-based modeling of the inhaled airflow physics within the anatomical domains was coupled with a Lagrangian particle-tracking framework to derive the drug deposition trend at the nasopharynx. The resulting globally averag

Hydroxyapatite nanoparticles (HANs) have emerged as a promising candidate for targeted drug delivery in the treatment of colon cancer, a disease that remains one of the leading causes of cancer-related deaths globally. In this study, we synthesized and characterized HANs for their potential use as drug delivery vehicle for anticancer drugs specifically targeting colon cancer treatment. Through various in vitro assays, including drug loading efficiency, release kinetics, we demonstrated that HANs exhibit efficient drug loading capacity, and sustained release behavior, which could collectively contribute to enhanced therapeutic outcomes against colon cancer cells. The findings highlight the potential of HANs to serve as a versatile platform for the targeted drug delivery of chemotherapeutic agents, offering a novel approach that could improve treatment efficacy while minimizing side effects due to biocompatibility of the particles. Future research should focus on in vivo studies and clinical translation to further validate the potential of HANs in cancer therapy as drug carrier.

The role of Artificial Intelligence (AI) is growing in every stage of drug development. Nevertheless, a major challenge in drug discovery AI remains: Drug pharmacokinetic (PK) and Drug-Target Interaction (DTI) datasets collected in different studies often exhibit limited overlap, creating data overlap sparsity. Thus, data curation becomes difficult, negatively impacting downstream research investigations in high-throughput screening, polypharmacy, and drug combination. We propose xImagand-DKI, a novel SMILES/Protein-to-Pharmacokinetic/DTI (SP2PKDTI) diffusion model capable of generating an array of PK and DTI target properties conditioned on SMILES and protein inputs that exhibit data overlap sparsity. We infuse additional molecular and genomic domain knowledge from the Gene Ontology (GO) and molecular fingerprints to further improve our model performance. We show that xImagand-DKI-generated synthetic PK data closely resemble real data univariate and bivariate distributions, and can adequately fill in gaps among PK and DTI datasets. As such, xImagand-DKI is a promising solution for data overlap sparsity and may improve performance for downstream drug discovery research tasks. Code

This paper presents innovative designs for 3D-printed tumbling microrobots, specifically engineered for targeted in vivo drug delivery applications. The microrobot designs, created using stereolithography 3D printing technologies, incorporate permanent micro-magnets to enable actuation via a rotating magnetic field actuator system. The experimental framework encompasses a series of locomotion characterization tests to evaluate microrobot performance under various conditions. Testing variables include variations in microrobot geometries, actuation frequencies, and environmental conditions, such as dry and wet environments, and temperature changes. The paper outlines designs for three drug loading methods, along with comprehensive assessments thermal drug release using a focused ultrasound system, as well as biocompatibility tests. Animal model testing involves tissue phantoms and in vivo rat models, ensuring a thorough evaluation of the microrobots' performance and compatibility. The results highlight the robustness and adaptability of the proposed microrobot designs, showcasing the potential for efficient and targeted in vivo drug delivery. This novel approach addresses current lim

Colorectal cancer (CRC) remains a leading cause of cancer-related mortality worldwide, highlighting the urgent need for advanced therapeutic strategies. Nanoparticle-based drug delivery systems have emerged as a promising approach to improve the specificity and efficacy of anticancer treatments. This review examines three cutting-edge mesoporous silica nanoparticle (MSN)-based drug delivery to introduce novel CRC therapy, each utilizing unique functionalization strategies for targeted drug release. The first system, hyaluronidase-responsive MSN-HA/DOX, employs biotin-modified hyaluronic acid to facilitate dual-stimulus drug release in the tumor microenvironment, exhibiting enhanced in vivo tumor inhibition. The DOX/SLN-PEG-Biotin utilizes polyethylene glycol and biotin to improve drug stability and target biotin-overexpressing CRC cells, demonstrating superior anti-cancer efficacy in vitro and in vivo. Lastly, galactosylated chitosan-functionalized MSNs enable targeted delivery through asialoglycoprotein receptors, providing controlled drug release and strong therapeutic potential. Collectively, these systems highlight the advancements in nanoparticle functionalization for CRC trea

Accurate drug target affinity prediction can improve drug candidate selection, accelerate the drug discovery process, and reduce drug production costs. Previous work focused on traditional fingerprints or used features extracted based on the amino acid sequence in the protein, ignoring its 3D structure which affects its binding affinity. In this work, we propose GraphPrint: a framework for incorporating 3D protein structure features for drug target affinity prediction. We generate graph representations for protein 3D structures using amino acid residue location coordinates and combine them with drug graph representation and traditional features to jointly learn drug target affinity. Our model achieves a mean square error of 0.1378 and a concordance index of 0.8929 on the KIBA dataset and improves over using traditional protein features alone. Our ablation study shows that the 3D protein structure-based features provide information complementary to traditional features.

Intra-body nanonetworks hold promise for advancing targeted drug delivery (TDD) systems through molecular communications (MC). In the baseline MC-TDD system, drug-loaded nanomachines (DgNs) are positioned near the infected tissues to deliver drug molecules directly. To mitigate the decline in drug delivery efficiency caused by diffusion, we propose an enhanced MC-TDD system with a relay network. This network employs a novel localization-enabled relaying mechanism, where a nano-controller broadcasts a localization signal. DgNs then measure the received signal strength against thresholds to determine their clusters relative to the infected tissue. Additionally, our study considers the effect of multiple absorbing DgNs on the channel impulse response (CIR), a factor overlooked in previous works. Our approach improves drug delivery efficiency by $17\%$ compared to the baseline system. Importantly, we find that optimizing CIR is crucial for enhancing drug delivery efficiency. These findings pave the way for further research into optimizing CIR-based relay selection, as well as investigating the impact of factors such as drug molecule lifespan, obstruction probabilities, and flow dynamic

Longer timelines and lower success rates of drug candidates limit the productivity of clinical trials in the pharmaceutical industry. Promising de novo drug design techniques help solve this by exploring a broader chemical space, efficiently generating new molecules, and providing improved therapies. However, optimizing for molecular characteristics found in approved oral drugs remains a challenge, limiting de novo usage. In this work, we propose NovoMol, a novel de novo method using recurrent neural networks to mass-generate drug molecules with high oral bioavailability, increasing clinical trial time efficiency. Molecules were optimized for desirable traits and ranked using the quantitative estimate of drug-likeness (QED). Generated molecules meeting QED's oral bioavailability threshold were used to retrain the neural network, and, after five training cycles, 76% of generated molecules passed this strict threshold and 96% passed the traditionally used Lipinski's Rule of Five. The trained model was then used to generate specific drug candidates for the cancer-related PDGFRα receptor and 44% of generated candidates had better binding affinity than the current state-of-the-art drug,

Alzheimer's disease (AD) is a devastating neurodegenerative disorder with no cure and limited treatment solutions that are unable to target any of the suspected causes. Increasing evidence suggests that one of the causes of neurodegeneration is the overproduction of amyloid beta (A\b{eta}) and the inability of A\b{eta} peptides to be cleared from the brain, resulting in self-aggregation to form toxic oligomers, fibrils and plaques. One of the potential treatment options is to target A\b{eta} and prevent self-aggregation to allow for a natural clearing of the brain. In this paper, we review the drugs and drug delivery systems that target A\b{eta} in relation to Alzheimer's disease. Many attempts have been made to use anti-A\b{eta} targeting molecules capable of targeting A\b{eta} (with much success in vitro and in vivo animal models), but the major obstacle to this technique is the challenge posed by the blood brain barrier (BBB). This highly selective barrier protects the brain from toxic molecules and pathogens and prevents the delivery of most drugs. Therefore novel A\b{eta} aggregation inhibitor drugs will require well thought-out drug delivery systems to deliver sufficient conc

The integration of biosensing platforms with drug delivery systems has led to effective treatment strategies for biomedical applications. With the emergency of nanotechnology, the manipulation of materials in the nanometer, these biosensing and drug delivery systems have been tremendously improved due to the exceptional properties exhibited by these materials. The conventional approaches used to synthesize the nanomaterials including physical and chemical methods involve the usage of harsh chemicals and hazardous reaction conditions and hence posing a threat to health and the environment. This problem is solved by the biological methods that involve green nanotechnology which integrates green chemistry and engineering principles to formulate harmless and eco-friendly nanomaterials to fight the complications affecting human health and the environment. These biological methods use phytochemicals found in plants and plants parts as well as microorganisms for the bioreduction of metal ions to their corresponding nanomaterials. The plants and the microorganisms are readily available, cost-efficient, and have biocompatibility hence offering sustainable synthetic methods for nanomaterials

Nanovectors (NVs), based on nanostructured matter such as nanoparticles (NPs), have proven to perform as excellent drug delivery systems. However, due to the great variety of potential NVs, including NPs materials and their functionalization, in addition to the plethora of molecules that could transport, this fields presents a great challenge in terms of resources to find NVs with the most optimal physicochemical properties such as particle size and drug loading, where most of efforts rely on trial and error experimentation. In this regard, Artificial intelligence (AI) and metaheuristic algorithms offer efficient of the state-of-the-art modelling and optimization, respectively. This review focuses, through a systematic search, on the use of artificial intelligence and metaheuristic algorithms for nanoparticle synthesis in drug delivery systems. The main findings are: neural networks are better at modelling NVs properties than linear regression algorithms and response surface methodology, there is a very limited number of studies comparing AI or metaheuristic algorithm, and there is no information regarding the appropriateness of calculations of the sample size. Based on these findi

Despite all the advances achieved in the field of tumor-biology research, in most cases conventional therapies including chemotherapy are still the leading choices. The main disadvantage of these treatments, in addition to the low solubility of many antitumor drugs, is their lack of specificity, which explains the frequent occurrence of serious side effects due to nonspecific drug uptake by healthy cells. Progress in nanotechnology and its application in medicine have provided new opportunities and different smart systems. Such systems can improve the intracellular delivery of the drugs due to their multifunctionality and targeting potential. The purpose of this manuscript is to review and analyze the recent progress made in nanotherapy applied to cancer treatment. First, we provide a global overview of cancer and different smart nanoparticles currently used in oncology. Then, we analyze in detail the development of drug-delivery strategies in cancer therapy, focusing mainly on the intravenously administered smart nanoparticles with protein corona to avoid immune-system clearance. Finally, we discuss the challenges, clinical trials, and future directions of the nanoparticle-based t

Electroporation is a very useful tool for drug delivery into various diseased tissues of the human body. This technique helps to improve the clinical treatment by transferring drugs into the targeted cells rapidly. In electroporation, drug particles enter easily into the intracellular compartment through the temporarily permeabilized cell membrane due to the applied electric field. In this work, a mathematical model of drug delivery focusing on reversible tissue electroporation is presented. In addition, the thermal effects on the tissue, which is an outcome of Joule heating, are also considered. This model introduces a time-dependent mass transfer coefficient, which is significant to drug transport. Multiple pulses with low voltage are applied to reach sufficient drugs into the targeted cells. According to the physical circumstances, a set of differential equations are considered and solved. The changes in drug concentration with different parameters (e.g., diffusion coefficient, drug permeability, pulse length, and pulse number) are analyzed. The model optimizes the electroporation parameters to uptake drugs sufficiently into the cells with no thermal damage. This model can be us

Drug delivery systems represent a promising strategy to treat cancer and to overcome the side effects of chemotherapy. In particular, polymeric nanocontainers have attracted major interest because of their structural and morphological advantages and the variety of polymers that can be used, allowing the synthesis of materials capable of responding to the biochemical alterations of the tumour microenvironment. While experimental methodologies can provide much insight, the generation of experimental data across a wide parameter space is usually prohibitively time consuming and/or expensive. To better understand the influence of varying design parameters on the drug release profile and drug kinetics involved, appropriately-designed mathematical models are of great benefit. Here, we developed a novel mathematical model to describe drug transport within, and release from, a hollow nanocontainer consisting of a core and a pH-responsive polymeric shell. The two-layer mathematical model fully accounts for drug dissolution, diffusion and interaction with polymer. We generated experimental drug release profiles using daunorubicin and [Cu(TPMA)(Phenantroline)](ClO_4)_2 as model drugs, for whi

Tuberculosis (TB) remains a major global health concern, necessitating the exploration of novel drug delivery systems to combat the challenges posed by conventional approaches. We investigated the potential of monolayer transition metal dichalcogenides (TMDs) as an innovative platform for efficient and targeted delivery of antituberculosis drugs. Specifically, the electronic and optical properties of prominent TB drugs, isoniazid (INH) and pyrazinamide (PZA), adsorbed on tungsten diselenide (WSe2) and tungsten disulfide (WS2) monolayers were studied using first-principles calculations based on density functional theory (DFT). The investigation revealed that the band gaps of WSe2 and WS2 monolayers remain unaltered upon adsorption of PZA or INH, with negative adsorption energy indicating stable physisorption. We explored different vertical and horizontal configurations, and the horizontal ones were more stable. Moreover, the adsorbed drugs could be readily released by light within the visible or near-infrared (NIR) wavelength range. This opened up possibilities for their potential application in photothermal therapy, harnessing the unique properties of these 2D materials. The optica

In this work we develop and investigate mathematical and computational models that describe drug delivery from a contact lens during wear. Our models are designed to predict the dynamics of drug release from the contact lens and subsequent transport into the adjacent pre-lens tear film and post-lens tear film as well as into the ocular tissue (e.g. cornea), into the eyelid, and out of these regions. These processes are modeled by one dimensional diffusion out of the lens coupled to compartment-type models for drug concentrations in the various accompanying regions. In addition to numerical solutions that are compared with experimental data on drug release in an in vitro eye model, we also identify a large diffusion limit model for which analytical solutions can be written down for all quantities of interest, such as cumulative release of the drug from the contact lens. We use our models to make assessments about possible mechanisms and drug transport pathways through the pre-lens and post-lens tear films and provide interpretation of experimental observations. We discuss successes and limitations of our models as well as their potential to guide further research to help understand

Nanoparticle drug carriers play an important role in facilitating efficient targeted drug delivery, i.e., improving treatment success and reducing drug costs and side effects. However, the mobility of nanoparticle drug carriers poses a challenge in designing drug delivery systems. Moreover, healing results critically depend on the rate and time duration of drug absorption. Therefore, in this paper, we aim to design a controlled-release drug delivery system with a mobile drug carrier that minimizes the total amount of released drugs while ensuring a desired rate of drug absorption during a prescribed time period. We model the mobile drug carrier as a mobile transmitter, the targeted diseased cells as an absorbing receiver, and the channel between the transceivers as a time-variant channel since the carrier mobility results in a time-variant absorption rate of the drug molecules. Based on this, we develop a molecular communication (MC) framework to design the controlled-release drug delivery system. In particular, we develop new analytical expressions for the mean, variance, probability density function, and cumulative distribution function of the channel impulse response (CIR). Equi

Local drug delivery has received much recognition in recent years, yet it is still unpredictable how drug efficacy depends on physicochemical properties and delivery kinetics. The purpose of the current study is to provide a useful mathematical model for drug release from a drug delivery device and consecutive drug transport in biological tissue, thereby aiding the development of new therapeutic drug by a systemic approach. In order to study the complete process, a two-layer spatio-temporal model depicting drug transport between the coupled media is presented. Drug release is described by considering solubilisation dynamics of drug particle, diffusion of the solubilised drug through porous matrix and also some other processes like reversible dissociation / recrystallization, drug particle-receptor binding and internalization phenomena. The model has led to a system of partial differential equations describing the important properties of drug kinetics. This model contributes towards the perception of the roles played by diffusion, mass-transfer, particle binding and internalization parameters.